Turley James S

Turley James S has demonstrated a consistent buying bias across three companies—Precigen Inc. (PGEN), Citigroup Inc. (C), and Emerson Electric Co. (EMR)—with no recorded sales in 29 reported transactions. The total buy value amounts to $253,654.80, with the largest single purchase occurring on March 10, 2026, when Turley acquired $62,499.06 worth of PGEN shares. Citigroup has been the most frequent investment, with multiple acquisitions dating back to 2024, including two $22,028.25 purchases on January 2, 2026, and smaller transactions averaging around $1,200-$1,700 in value. Emerson Electric appears less frequently in the filings, with no dollar value reported for the most recent transaction on February 3, 2026. The pattern suggests a long-term accumulation strategy, particularly in Citigroup, where Turley has executed quarterly purchases since at least 2024. While the PGEN investment in March 2026 stands out as the largest single transaction, the absence of any sales indicates a holding strategy across all positions. The filings do not disclose officer titles, leaving the nature of Turley’s relationship to these companies unclear. However, the exclusive focus on buying—without a single sale—points to sustained confidence in these holdings, particularly in financial and biotech sectors represented by C and PGEN.